Keeping Track: GSK Earns New Claims For Shingrix, Nucala; Keytruda’s TNBC Label Grows; CRL For Iterum

 
• By Bridget Silverman and Brenda Sandburg
  
Keeping Track Feature image

More from US FDA Performance Tracker

More from Regulatory Trackers